Calliditas Therapeutics AB (publ) (CALT)

CALT Revenue

In the year 2023, Calliditas Therapeutics AB (publ) had annual revenue of $119.73M with 55.09% growth.

• Revenue (ttm): $119.73M
• Revenue Growth: +55.09%
• P/S Ratio: 8.69
• Revenue / Employee: $551,756
• Employees: 217
• Market Cap: 1.04B USD

Revenue Chart

* The company reports in SEK currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	119.73M	42.53M	55.09%
Dec 31, 2022	77.20M	51.72M	202.95%
Dec 31, 2021	25.48M	25.38M	23,808.62%
Dec 31, 2020	106.59K	-19.77M	-99.46%
Dec 31, 2019	19.87M	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.